1. Home
  2. ARRY vs CDNA Comparison

ARRY vs CDNA Comparison

Compare ARRY & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARRY
  • CDNA
  • Stock Information
  • Founded
  • ARRY 1989
  • CDNA 1998
  • Country
  • ARRY United States
  • CDNA United States
  • Employees
  • ARRY N/A
  • CDNA N/A
  • Industry
  • ARRY Semiconductors
  • CDNA Medical Specialities
  • Sector
  • ARRY Technology
  • CDNA Health Care
  • Exchange
  • ARRY Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • ARRY 917.7M
  • CDNA 944.1M
  • IPO Year
  • ARRY 2020
  • CDNA 2014
  • Fundamental
  • Price
  • ARRY $6.04
  • CDNA $23.65
  • Analyst Decision
  • ARRY Buy
  • CDNA Buy
  • Analyst Count
  • ARRY 23
  • CDNA 8
  • Target Price
  • ARRY $13.08
  • CDNA $28.00
  • AVG Volume (30 Days)
  • ARRY 8.2M
  • CDNA 953.5K
  • Earning Date
  • ARRY 11-07-2024
  • CDNA 11-04-2024
  • Dividend Yield
  • ARRY N/A
  • CDNA N/A
  • EPS Growth
  • ARRY N/A
  • CDNA N/A
  • EPS
  • ARRY N/A
  • CDNA N/A
  • Revenue
  • ARRY $982,190,000.00
  • CDNA $312,775,000.00
  • Revenue This Year
  • ARRY N/A
  • CDNA $19.60
  • Revenue Next Year
  • ARRY $29.56
  • CDNA $10.26
  • P/E Ratio
  • ARRY N/A
  • CDNA N/A
  • Revenue Growth
  • ARRY N/A
  • CDNA 5.26
  • 52 Week Low
  • ARRY $5.56
  • CDNA $6.92
  • 52 Week High
  • ARRY $20.15
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • ARRY 43.63
  • CDNA 42.46
  • Support Level
  • ARRY $5.91
  • CDNA $20.77
  • Resistance Level
  • ARRY $7.73
  • CDNA $24.85
  • Average True Range (ATR)
  • ARRY 0.48
  • CDNA 1.19
  • MACD
  • ARRY -0.04
  • CDNA 0.22
  • Stochastic Oscillator
  • ARRY 9.63
  • CDNA 70.67

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

Share on Social Networks: